Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis: A Single-Center, Single-Arm Study

NCT07339566 is registered in ClinicalTrials.gov with Lingli Dong as lead sponsor.

NCT NCT07339566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07339566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis: A Single-Center, Single-Arm Study
Lead sponsor
Lingli Dong
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
January 30, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-radiographical axial spondyloarthritis, nr-axial spondyloarthritis